Shanghai Zhangjiang Hi-Tech Park Development

Shanghai Zhangjiang Hi-Tech Park Development operates one of China’s largest science parks focused on high-tech industries including life sciences and pharmaceuticals. It provides real estate development, investment management services for R&D facilities and innovation clusters that host hundreds of leading multinational pharmaceutical firms as well as Chinese biotechs. The park is home to over 400 innovation-driven companies in the biomedical sector alone—including Novartis, Roche Pfizer, AstraZeneca—and has become known as “China’s Silicon Valley” for life sciences research and commercialization. The company also acts as an early-stage investor via government-backed funds targeting hardtech startups in integrated circuits, biomedicine and AI.